GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EMC Instytut Medyczny SA (WAR:EMC) » Definitions » Risk Assessment

EMC Instytut Medyczny (WAR:EMC) Risk Assessment


View and export this data going back to 2005. Start your Free Trial

What is EMC Instytut Medyczny Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of EMC Instytut Medyczny is: High Risk: High uncertainty with risk-return tradeoff.


Competitive Comparison of EMC Instytut Medyczny's Risk Assessment

For the Medical Care Facilities subindustry, EMC Instytut Medyczny's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EMC Instytut Medyczny's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EMC Instytut Medyczny's Risk Assessment distribution charts can be found below:

* The bar in red indicates where EMC Instytut Medyczny's Risk Assessment falls into.



EMC Instytut Medyczny  (WAR:EMC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


EMC Instytut Medyczny Risk Assessment Related Terms

Thank you for viewing the detailed overview of EMC Instytut Medyczny's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


EMC Instytut Medyczny (WAR:EMC) Business Description

Traded in Other Exchanges
N/A
Address
ul. Pilczycka 144-148, Wroclaw, POL, 54-144
EMC Instytut Medyczny SA owns and operates hospitals and clinics in Poland. It offers specialized advice, full diagnostics, hospital treatment, care for older people in specialized centers or home conditions. It also offers services including private medical care, specialized consultations, primary health care, outpatient rehabilitation, long-term care and 24hours medical europaservice.

EMC Instytut Medyczny (WAR:EMC) Headlines

From GuruFocus

Michael Price Sells Dolby Labs, EMC

By Tiziano Frateschi Tiziano Frateschi 11-21-2016

4 Tech Ideas From Gurus as Nasdaq Hits Low Levels

By Sheila Dang Sheila Dang 01-19-2016

Eric Mindich Makes 10 New Buys in 4th Quarter

By David Goodloe David Goodloe 03-07-2016

Jeremy Grantham's GMO Ups Stake in EMC Corp.

By Kyle Ferguson Kyle Ferguson 02-15-2016

Investors Can Rely On EMC For Good Returns

By gunjinvest gunjinvest 11-10-2014

John Paulson Goes Virtual

By Sydnee Gatewood Sydnee Gatewood 08-16-2016

David Rolfe Comments on EMC

By Holly LaFon 10-15-2015

Daniel Loeb Comments on EMC Corp

By Holly LaFon Holly LaFon 11-02-2016

Daniel Loeb Gives Third Point 3rd Quarter Shareholder Letter

By Holly LaFon Holly LaFon 11-02-2016

Cloud Growth and Key Products Can Lead EMC Higher

By RHPanalysts RHPanalysts 11-25-2014